Simultaneous Determination of Plasma Concentrations of 2 Components of Lrbesartan Hydrochlorothiazide Tablet and Bioequivalence Study of It

HUA Wen-yan,HUANG Ming,WANG Meng,SHI Ai-ming,ZHOU Wen-jia,ZHANG Quan-ying

2011-01-01

Abstract:OBJECTIVE: To develop the simultaneous determination method of irbesartan and hydrochlorothiazide in human plasma, and to evaluate the bioequivalence of 2 kinds of Irbesartan hydrochlorothiazide tablets. METHODS: Telmisartan was used as the internal standard. Plasma sample was extracted with acetonitrile and centrifuged. LC-MS/MS method was adopted and the determination was performed on Waters XTerra RP18(150 mm×4.6 mm,5 μm)column with acetonitrile-1 mmol·L-1 ammonium acetate buffer solution (pH adjusted to 9.0 using ammonia water)(35∶65) as mobile phase. Mass charge ratio of ion pair irbesartan was m/z -427.3→-193.0 and that of hydrochlorothiazide was m/z -296.0→-122.9. The bioequivalence of test preparation and reference preparation of Irbesartan hydrochlorothiazide tablets in 18 healthy volunteers after oral administration were investigated in randomized double-cycle cross-over design. RESULTS: The linear ranges were 2.00～5 000 μg·L-1 for irbesartan(r=0.998 4)and 2.00～200 μg·L-1 for hydrochlorothiazide (r=0.998 8). The lowest limits of quantization were 2.00 μg ·L-1. The recovery rate was above 90%, and the intra-day and inter-day RSDs were both less than 10%. The recoveries of irbesartan ranged 96.3%～108.0%, and that of hydrochlorothiazide ranged 98.2%～100.5%. There were no significant difference in cmax, AUC0～t, AUC0～∞ between two preparation and cycles (P0.05). There was no significant differenc in tmax between two preparations in non-parameter test (P0.05). CONCLUSION: The method is simple in pretreatment and is specific, rapid, and accurate in analysis. The method can simultaneously determine plasma concentration of irbesartan and hydrochlorothiazide quantitatively. Two preparations are bioequivalent.